The Cohorts · Quarterly vintage
Inception 2024-07-01 · 2.2 years held
Q3 2024 · Top 10.
On 2024-07-01, these 10 businesses were the 10most-undervalued names in our coverage universe by Mr. Market's protocol. We've held them, equal-weighted, since.
Q3 2024 · Top 10 · since inception
+43.6%
CAGR 17.9% annualised
S&P 500 · since inception
+43.5%
CAGR 17.8% annualised
Spread
+0.1%
This cohort has beaten the index.
Other cohorts at the same inception
The constituents.
Ranked, on the inception date, by Δ% to intrinsic value. Each holding is equal-weighted at 10.0% of the portfolio.
| Rank | Ticker | Entry price | Entry IV | Entry Δ% | Current price | Return | Contribution | |
|---|---|---|---|---|---|---|---|---|
| 1 | BAC | $38.03 | $357.13 | +839.2% | $62.69 | +64.9% | +6.5% | Read → |
| 2 | OXY | $60.15 | $425.31 | +607.1% | $61.46 | +2.2% | +0.2% | Read → |
| 3 | CAT | $319.76 | $1,949.81 | +509.8% | $818.57 | +156.0% | +15.6% | Read → |
| 4 | JNJ | $137.68 | $723.63 | +425.6% | $265.58 | +92.9% | +9.3% | Read → |
| 5 | GOOGL | $181.47 | $824.82 | +354.5% | $338.50 | +86.5% | +8.7% | Read → |
| 6 | META | $501.31 | $2,241.31 | +347.1% | $648.03 | +29.3% | +2.9% | Read → |
| 7 | CVX | $142.46 | $610.25 | +328.4% | $214.06 | +50.3% | +5.0% | Read → |
| 8 | NKE | $72.44 | $376.33 | +321.6% | $36.80 | -49.2% | -4.9% | Read → |
| 9 | LOW | $204.30 | $954.78 | +313.1% | $196.82 | -3.7% | -0.4% | Read → |
| 10 | MCD | $236.78 | $809.72 | +242.0% | $252.53 | +6.6% | +0.7% | Read → |
Biggest contributors
Where the cohort earned its keep.
- CAT · $319.76 → $818.57+156.0%
- JNJ · $137.68 → $265.58+92.9%
- GOOGL · $181.47 → $338.50+86.5%
Biggest detractors
Where the protocol got it wrong.
- NKE · $72.44 → $36.80-49.2%
- LOW · $204.30 → $196.82-3.7%